Literature DB >> 12786868

Alopecia areata: psychiatric comorbidity and adjustment to illness.

Sergio Ruiz-Doblado1, Ana Carrizosa, Maria Jose García-Hernández.   

Abstract

BACKGROUND: Decades ago, alopecia areata (AA) was regarded as a well-known example of psychosomatic disease. The poor development of measurement methods and criteria for the classification of psychiatric disorders at that time was probably partly to blame for the lack of methodologic validity of some studies.
METHODS: We studied a random sample of 32 patients with AA (patchy form). Sociodemographic, dermatologic, and psychiatric variables were collected. Psychiatric examination was carried out by standardized interviews: Schedules for Clinical Assessment in Neuropsychiatry (SCAN), International Personality Disorders Examination (IPDE), and Psychological Adjustment to Illness Scale (PAIS), using the Research Diagnostic Criteria of the International Classification of Diseases, 10th edition, to assess the diagnosis. A descriptive and association study was performed, correlating the patient's adjustment and adaptation to the illness to various factors (linear regression techniques and analysis of variance).
RESULTS: Sixty-six per cent of patients presented with psychiatric comorbidity, mainly adjustment disorders (F.43.2), generalized anxiety disorders (F.41.1), and depressive episodes (F.32). Overall adaptation to the illness, however, was satisfactory, showing few repercussions in family or social life, work, or sexual adjustment. Poor adjustment was associated with a dependent personality (Pearson's r = 0.66), antisocial personality (r = 0.39), generalized anxiety (P = 0.003), and depression (P = 0.02).
CONCLUSIONS: There is a high psychiatric comorbidity in AA (anxiety and mood disorders), requiring systematic psychiatric evaluations of these patients. A satisfactory overall adaptation to mild/moderate forms of the disease is the norm, but adaptation and comorbidity in severe forms (totalis, universalis) are unknown. A dermatology/liaison psychiatry setting could improve the management of AA.

Entities:  

Mesh:

Year:  2003        PMID: 12786868     DOI: 10.1046/j.1365-4362.2003.01340.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  29 in total

1.  Postoperative pressure-induced alopecia after segmental osteotomy at the upper and lower frontal edentulous areas for distraction osteogenesis.

Authors:  Kazuhiro Matsushita; Nobuo Inoue; Kazuhiro Ooi; Yasunori Totsuka
Journal:  Oral Maxillofac Surg       Date:  2011-09

2.  Postoperative permanent pressure alopecia.

Authors:  Zi Yun Chang; Jan Ngian; Claudia Chong; Chin Ted Chong; Qui Yin Liew
Journal:  J Anesth       Date:  2015-11-26       Impact factor: 2.078

Review 3.  The psychological impact of alopecia.

Authors:  Nigel Hunt; Sue McHale
Journal:  BMJ       Date:  2005-10-22

4.  Patches of hair loss on the scalp.

Authors:  Patricia T Ting; Benjamin Barankin
Journal:  Can Fam Physician       Date:  2006-08       Impact factor: 3.275

Review 5.  Alopecia areata: Part 2: treatment.

Authors:  Frank Spano; Jeff C Donovan
Journal:  Can Fam Physician       Date:  2015-09       Impact factor: 3.275

6.  Emotional Consequences of Finasteride: Fool's Gold.

Authors:  Christine Anne Ganzer; Alan Roy Jacobs
Journal:  Am J Mens Health       Date:  2016-02-11

7.  Importance of Group Therapeutic Support for Family Members of Children with Alopecia Areata: A Cross-Sectional Survey Study.

Authors:  Kelly A Aschenbeck; Sarah L McFarland; Maria K Hordinsky; Bruce R Lindgren; Ronda S Farah
Journal:  Pediatr Dermatol       Date:  2017-05-16       Impact factor: 1.588

Review 8.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

9.  Alopecia areata: a new treatment plan.

Authors:  Adel Alsantali
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-07-22

10.  Current treatment strategies in pediatric alopecia areata.

Authors:  Etienne Wang; Joyce Ss Lee; Mark Tang
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.